Zanosar

Zanosar (Streptozocin) is an intravenous chemotherapy medication used primarily for pancreatic cancer treatment. This alkylating agent targets specific cancer cells while minimizing impact on healthy tissue. Always consult a healthcare professional for personalized guidance.

Zanosar is primarily used to treat pancreatic cancer, including islet cell carcinoma. It may also be prescribed for other cancer types when recommended by an oncologist. The medication works by interfering with cancer cell growth and division. Patients often ask, 'What is Zanosar used for?' to understand its role in cancer therapy.

Zanosar may cause nausea, vomiting, or fatigue during treatment. Some patients experience changes in kidney function, which are typically monitored by healthcare providers. Hair loss and low blood cell counts are also possible effects. These responses vary widely among individuals.

Zanosar should only be administered under medical supervision due to its potent effects. Patients with kidney or liver conditions require careful monitoring during treatment. Avoid exposure to infections and maintain hydration as directed. Always disclose your full medical history to your healthcare provider before starting this medication.

Zanosar may interact with other chemotherapy drugs, immunosuppressants, or medications affecting kidney function. Alcohol and certain herbal supplements could amplify side effects. Always inform your doctor about all medications and supplements you are taking. Some interactions may require dose adjustments or alternative treatments.